Immediate Impact
58 standout
Citing Papers
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
2024 Standout
Works of Marc Pittman being referenced
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
2020
Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marc Pittman | 127 | 134 | 85 | 106 | 9 | 343 | |
| Hiroki Oyanagi | 62 | 139 | 12 | 63 | 13 | 347 | |
| G. Mair | 53 | 59 | 41 | 24 | 11 | 305 | |
| G Righetti | 46 | 207 | 40 | 22 | 15 | 326 | |
| Diane M. Pierson | 29 | 109 | 39 | 61 | 11 | 318 | |
| Stefanie Stepanow | 39 | 129 | 112 | 47 | 11 | 336 | |
| L B Conanan | 26 | 64 | 18 | 81 | 14 | 375 | |
| Adhid Al-Arif | 29 | 158 | 83 | 15 | 11 | 336 | |
| Rong H. Zhang | 74 | 199 | 19 | 41 | 8 | 385 | |
| Roxanne Steinle | 97 | 128 | 57 | 13 | 14 | 344 | |
| Luz Agana | 99 | 126 | 48 | 36 | 8 | 386 |
All Works
Login with ORCID to disown or claim papers
Loading papers...